Hypomethylating agents in combination with histone deacetylase inhibitors in higher risk myelodysplastic syndromes: Is there a light at the end of the tunnel? | Aplastic Anemia and MDS International Foundation

Hypomethylating agents in combination with histone deacetylase inhibitors in higher risk myelodysplastic syndromes: Is there a light at the end of the tunnel?

Journal Title: 
Cancer
Primary Author: 
Stahl M
Author(s): 
Stahl M, Zeidan AM
Original Publication Date: 
Tuesday, January 17, 2017

No abstract available.

Bone Marrow Diseases: